Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-024704

Options or other derivatives

  • Director acquired 208,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Haddadin Yezan Munther Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +56,636 56,636 D
Haddadin Yezan Munther Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +132,293 132,293 D
Haddadin Yezan Munther Director 2024-10-03 Grant or award · Stock Option (Right to Buy) +19,771 19,771 D
Loading xslF345X05/form4-10032024_081007.xml…